Page 42 - Irwin Simon News Today

Tilray and Aphria combo to be big on global stage FILE: Irwin Simon is pictured among rows of cannabis plants at Aphria Inc., in Leamington, Ont. on Oct. 25, 2019. / Photo by Dax Melmer /Windsor Star It’s a done deal for the merging of Tilray, Inc. and Aphria Inc., two Canadian cannabis giants, said to create a weed-focused company with the largest global geographic footprint in the industry. First announced in December, the business combination means the new company operating as Tilray...

On Monday, Tilray, Inc. (NASDAQ:TLRY) and Aphria, Inc. (NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with Irwin Simon, CEO of the new combined company. Check out the video below: Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23. Jazz Pharmaceuticals (NASDAQ:JAZZ) finalized its acquisition of GW Pharmaceutical...

Every Tuesday and Friday, WTR presents a round-up of news, developments and insights from across the trademark sphere. In our latest round-up, we look at Nextbite adding more celebrity virtual brands to its portfolio, Native American tribes including tribal insignias in the USPTOs database for free, Tilray announcing big plans for its cannabis brands, and much more. Coverage this time from Bridget Diakun (BD), Tim Lince (TJL) and Trevor Little (TL). Market radar: Premier Inc joins coalition to...

Tilray and Aphria combo to be big on global stage FILE: Irwin Simon is pictured among rows of cannabis plants at Aphria Inc., in Leamington, Ont. on Oct. 25, 2019. / Photo by Dax Melmer /Windsor Star It’s a done deal for the merging of Tilray, Inc. and Aphria Inc., two Canadian cannabis giants, said to create a weed-focused company with the largest global geographic footprint in the industry. First announced in December, the business combination means the new company operating as Tilray...

Welcome to this weeks Insider Cannabis. First off, my interview with Aurora Cannabis CEO Miguel Martin seemed to have struck a chord with readers on social media — many did not appreciate the thought of comparing cannabis to Monsanto, a company that was often a lightning rod for criticism over GMOs and pesticides and their role in our food supply and agricultural economy. Despite that, the point stands: Cannabis is an agricultural commodity. Growing will shift to more cost-effective strategie...

May 6, 2021 08:56 pm By Chloe Aiello Share with On the back of a megamerger with Aphria, the new Tilray is well-positioned to take advantage of global opportunities in cannabis, according to CEO Irwin Simon. “Tilray today has a footprint all around the world,” said Simon, who previously led Aphria. “We are participating in a $100 billion category with tremendous growth opportunities around our brands and the categories that we participate in.” The transaction closed Monday after shareho...

Tilray Becomes Pot’s Biggest As Investors Say Good-Bye to Aphria Stock InvestorPlace 5/5/2021 © Source: Jarretera / Shutterstock.com Tilray (TLRY) logo on a web browser. If you’re an investor who’s been waiting to make your marijuana move, the end of Aphria (NASDAQ: Tilray (NASDAQ: © Provided by InvestorPlace Tilray (TLRY) logo on a web browser. End of APHA stock, you say? Well, it is being delisted. But shareholders, who voted an astonishing 99.38% in favor of the merger, got...

Author Bio Howard grew up in Philadelphia watching the Philly sports teams struggle for championships. He has been investing since 1989 and been a Fool since 2001. Prior to joining The Fool as a contract writer in 2019, Howard worked in the steel business as an engineer for 28 years. When he isn’t writing, he is usually out for a run, or relaxing to the music of the Grateful Dead. Some Robinhood traders looking for what to buy in May might be planning to sell by June. ...

After Aphria Deal, the New Tilray Eyes Global Cannabis Brands May 04 2021, 7:49 AM May 03 2021, 9:11 PM May 04 2021, 7:49 AM (Bloomberg) -- Tilray Inc. shareholders approved the merger with Aphria Inc., creating a cannabis powerhouse that’s both the largest medical marijuana company in Europe and a major player in Canada’s recreational market. (Bloomberg) -- Tilray Inc. shareholders approved the merger with Aphria Inc., creating a cannabis powerhouse that’s both the largest medic...

Depression Scores Did Not Differ Significantly Between Patients Who Used Psilocybin or Escitalopram at 6 weeks These findings, from a phase 2, double-blind, randomized, controlled trial, were published in the New England Journal of Medicine. Patients (N=59) with long-standing, moderate to severe major depressive disorder were recruited via an advertisement in the United Kingdom in 2019. Patients were randomized to receive 2 doses of 25 mg psilocybin with a daily placebo for 6 weeks (n=30) or 2 ...